F-1: Inspira Technologies Files for Resale of Ordinary Shares and Warrant Shares

Inspira Technologies is registering the resale of up to 4,416,916 ordinary shares, including shares issued to executive officers and founders, and shares issuable upon exercise of outstanding warrants.

Summary

• Inspira Technologies has filed a registration statement for the resale of up to 4,416,916 ordinary shares.
• This includes 953,478 ordinary shares held by executive officers and founders, Dagi Ben-Noon and Joe Hayon.
• It also covers 3,463,438 ordinary shares issuable upon the exercise of outstanding warrants held by certain selling shareholders.
• The warrants have exercise prices ranging from $1.28 to $2.25 per share.
• The company will not receive any proceeds from the sale of these shares by the selling shareholders, except to the extent that the warrants are exercised for cash, which could result in gross proceeds of approximately $4.7 million.
• The company intends to use any proceeds from the exercise of the warrants for working capital and general corporate purposes.

Sentiment

Score: 5

Explanation: Neutral sentiment. The document primarily outlines the registration for resale of shares and warrants, with potential benefits from warrant exercises offset by risks related to market volatility and future financing needs.

Positives

• Potential influx of $4.7 million in gross proceeds if all warrants are exercised.
• Registration allows selling shareholders to offer and sell their shares, potentially increasing liquidity.
• The company intends to use any proceeds from the exercise of the warrants for working capital and general corporate purposes.

Negatives

• The company will not receive any proceeds from the sale of shares by the selling shareholders, unless warrants are exercised.
• Future sales of ordinary shares could reduce the market price of the company's securities.
• The market price of the ordinary shares may be volatile.

Risks

• Future sales of ordinary shares could reduce the market price of the company's securities.
• The company may need additional financing in the future, and may be unable to obtain it on favorable terms.
• The price of the ordinary shares may be volatile.
• The company has never paid cash dividends and does not anticipate paying any in the foreseeable future.
• The company's existing cash and cash equivalents may not be sufficient to fund operating expenses and capital requirements for the next twelve months.

Future Outlook

The company expects to require substantial additional capital to operate and commercialize its products and expects to seek additional funds to enable it to fund its operations for the next twelve months.

Industry Context

The company operates in the specialty medical device industry, focusing on life support technology. The company's goal is to set a new standard of care and to provide patients with acute respiratory failure an opportunity to maintain spontaneous breathing and avoid the need for intubation, coma and various risks associated with the use of Mechanical Ventilation.

Stakeholder Impact

• Shareholders may experience dilution if warrants are exercised.
• The market price of the ordinary shares may be volatile, affecting shareholder value.
• The company's ability to commercialize its products and fund operations depends on obtaining additional capital.

Next Steps

• The selling shareholders may sell all or a portion of the resale shares from time to time directly or through one or more underwriters, broker-dealers or agents.
• The company will use any proceeds from the exercise of the warrants for working capital and general corporate purposes.

Key Dates

Keywords

ordinary shares, warrants, resale, Inspira Technologies, selling shareholders, exercise price, registration statement, securities, offering